This is a summary of the European public assessment report (EPAR) for Desloratadine Actavis. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Desloratadine Actavis.
Therapeutic Indication
### Therapeutic indication Treatment of allergic rhinitis and urticaria.
Therapeutic Area (MeSH)
ATC Code
R06AX27
ATC Item
desloratadine
Pharmacotherapeutic Group
Antihistamines for systemic use
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| desloratadine | N/A | 地氯雷他定 |
EMA Name
Desloratadine Actavis
Medicine Name
Desloratadine Actavis
Aliases
N/ANo risk management plan link.
